TITAN PHARMACEUTICALS INC (CIK: 0000910267) EDGAR, Information, Filings... CompaniesBIO.Com

TITAN PHARMACEUTICALS INC

Mailing address
400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, Delaware, 94080
Phone
6502444990
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

TITAN PHARMACEUTICALS INC (CIK: 0000910267) is an American company incorporated in the state of California. Head office is located at 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, California, 94080. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). TITAN PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
NATAN DAVID	0001253108	Jul-26-2023	director
Beebe Katherine	0001768867	Jul-26-2023	director, officer: President and COO
McMurdo Matthew Charles	0001943108	Jul-26-2023	director
Chasey Peter Louis	0001943351	Jul-26-2023	director
Greenberg Eric Howard	0001943832	Jul-26-2023	director
Ben-Tzvi Avraham	0001944721	Jul-26-2023	director
Choong Choon Hau	0001986021	Jun-23-2023	10 percent owner
Activist Investing LLC	0001817604	Jan-24-2023	other: Member of 10% owner group
Lazar David E.	0001932843	Jan-24-2023	director, 10 percent owner, officer: Chief Executive Officer
MCNAB JAMES R	0001190126	Feb-10-2021	director
Akers Joseph A	0001379888	Feb-10-2021	director
Rubin Marc	0001412377	Feb-10-2021	director, officer: Executive Chairman
Hallberg Dane	0001768844	Feb-19-2019	officer: See Remarks
Recli Federico Seghi	0001739970	May-14-2018	director
Smith Scott Andrew	0001614975	Jan-02-2017	director
Kumar Rajinder	0001693951	Jan-02-2017	director
Harrison Seth Loring	0001404955	Nov-25-2013	10 percent owner
Braeburn Pharmaceuticals BVBA SPRL	0001593438	Nov-25-2013	10 percent owner
Apple Tree Investments S.a.r.l	0001593439	Nov-25-2013	10 percent owner
Apple Tree Partners IV, L.P.	0001593440	Nov-25-2013	10 percent owner
Apple Tree Consolidated BVBA SPRL	0001593452	Nov-25-2013	10 percent owner
ATP III GP, Ltd.	0001593453	Nov-25-2013	10 percent owner
Kapp Joachim Friedrich	0001338543	Aug-31-2005	director
AFTING ERNST GUNTER MD	0001180758	Sep-01-2004	director
MACFARLANE M DAVID	0001182314	Sep-01-2004	director
BAUER VICTOR J PHD	0001180756	Aug-16-2004	director
BHONSLE SUNIL	0001180755	Feb-09-2004	director, officer: Exec. VP & COO
ALLEN RICHARD C	0001180757	Feb-09-2004	officer: Executive Vice President
BUCALO LOUIS R MD	0001180760	Feb-09-2004	director, officer: President and CEO
FARRELL ROBERT EDWARD	0001182315	Feb-09-2004	officer: Exec VP & CFO
WEIS KONRAD M PHD	0001180753	Nov-26-2003	director
HSU MICHAEL	0001180752	Nov-18-2003	director
CAVALLER EURELIO M	0001180754	Oct-31-2003	director
SMITH LEY S	0001180759	Oct-31-2003	director
HUCKEL HUBERT E MD	0001121608	Oct-20-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TITAN PHARMACEUTICALS INC

Filings	Format	Description	Filed/Effective	File/Film Number
EFFECT	Document	Acc-no: 9999999995-25-003285 (33 Act) Size: KB	Nov-14-2025	333-262614 251489158
EFFECT	Document	Acc-no: 9999999995-25-003281 (33 Act) Size: KB	Nov-14-2025	333-252482 251489154
EFFECT	Document	Acc-no: 9999999995-25-003280 (33 Act) Size: KB	Nov-14-2025	333-251187 251489153
EFFECT	Document	Acc-no: 9999999995-25-003279 (33 Act) Size: KB	Nov-14-2025	333-249550 251489151
EFFECT	Document	Acc-no: 9999999995-25-003275 (33 Act) Size: KB	Nov-14-2025	333-221126 251489152
EFFECT	Document	Acc-no: 9999999995-25-003277 (33 Act) Size: KB	Nov-14-2025	333-230742 251489147
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001829126-25-008099 (34 Act) Size: KB	Oct-14-2025	001-13341 251391748
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001829126-25-008009 (33 Act) Size: KB	Oct-09-2025	333-171181 251385947
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001829126-25-008008 (33 Act) Size: KB	Oct-09-2025	333-262614 251385945
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001829126-25-008007 (33 Act) Size: KB	Oct-09-2025	333-252482 251385940
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001829126-25-008006 (33 Act) Size: KB	Oct-09-2025	333-207950 251385939
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001829126-25-008005 (33 Act) Size: KB	Oct-09-2025	333-251187 251385937
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001829126-25-008004 (33 Act) Size: KB	Oct-09-2025	333-275153 251385936
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001829126-25-008003 (33 Act) Size: KB	Oct-09-2025	333-249550 251385933
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001829126-25-008002 (33 Act) Size: KB	Oct-09-2025	333-233722 251385927
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001829126-25-007999 (33 Act) Size: KB	Oct-09-2025	333-221126 251385883
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001829126-25-007997 (33 Act) Size: KB	Oct-09-2025	333-230742 251385874
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000921895-25-002721 ( Act) Size: 0 KB	Oct-08-2025
25-NSE	Document	Acc-no: 0001354457-25-000977 (34 Act) Size: KB	Oct-02-2025	001-13341 251367100
8-K	Document	Current report filing Acc-no: 0001829126-25-007823 (34 Act) Size: KB	Oct-01-2025	001-13341 251364884

Recent 20 filings. View all TITAN PHARMACEUTICALS INC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

TITAN PHARMACEUTICALS INC overview
TITAN PHARMACEUTICALS INC job
TITAN PHARMACEUTICALS INC stock
TITAN PHARMACEUTICALS INC ownership
TITAN PHARMACEUTICALS INC CEO
TITAN PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.